Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial

Table 2

Effects of SXN on peripheral hemogram in IDA patients.

	Groups	n	RBC (×10^12/L)		MCV (fL)		MCH (pg)		MCHC (g/L)
			Pre-treatment	Post-treatment	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment	Pre-treatment	Post-treatment
Adult	L-SXN	400
	M-SXN	440
	H-SXN	801
Child	L-SXN	30
	M-SXN	149
	H-SXN	181

P< 0.05, P< 0.01, compared with pretreatment.